Skip to main content
Subscribe
  • Sign Up Free
  • Login
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Blogs
    • AI
    • Deals
    • Layoff Tracker
    • HIMSS 2023
  • Opinion
    • Breaking Bias
    • Commentaries
    • Letters
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Digital Health Transformation Summit
    • ESG: The Implementation Imperative Summit
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Hospital at Home
    • - Workplace of the Future
    • - AI and Digital Health
    • - Future of Staffing
    • - Hospital of the Future (Fall)
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Sponsored Video Series - One on One
    • Sponsored Video Series - Checking In with Dan Peres
  • Data & Insights
    • Data & Insights Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Government
March 10, 2014 12:00 AM

CMS backs off major changes to Medicare Part D

Virgil Dickson
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    Tavenner

    (Story updated at 8:10 a.m. ET on March 11. 2014.)

    The Obama administration backed away from major changes proposed for the Medicare Part D prescription drug program, providing political cover ahead of the mid-term elections this year—and disappointing community pharmacists, who say the White House also bowed to lobbying from drug companies.

    A draft policy that the CMS introduced in January was intended to control costs, decrease fraud and level the playing field for the private insurance plans that participate in the program. But many of the ideas outlined were nearly universally panned and would have created headaches for Democratic candidates asked to explain the policies, which included stripping a guarantee that Part D policies cover certain classes of drugs.

    “You have a program that has high approval, with 90% of Medicare beneficiaries ranking it positively, and you want to change it?" said Mary Grealy, president of Healthcare Leadership Council, a coalition of CEOs of healthcare companies, hospitals and universities. "That makes no sense, especially for those running for office this year.”

    The Healthcare Leadership Council initiated a letter—signed by 371 patient advocacy groups, drug manufacturers, health plans and provider organizations—asking CMS Administrator Marilyn Tavenner not to move forward with the changes.

    The proposed rule also provoked criticism from members of Congress in both parties. On Monday, Tavenner responded in a letter (PDF) to a bipartisan group of about 50 House members who urged her to change course.

    Gone is the controversial suggestion to set a higher standard for mandating that plans pay for “all or substantially all” drug offerings in six categories: antineoplastics, anticonvulsants, antiretrovirals, antipsychotics, antidepressants and immunosuppressants. The proposal specifically would have stripped the label from antidepressants, immunosuppressant and eventually antipsychotics.

    Also gone is a suggestion that each payer offer no more than two Part D plans in the same service area. So is a provision prohibiting Medicare Advantage plans from offering coverage options that replace plans that the CMS previously required the carrier to terminate or consolidate because of low enrollment. And finally, the CMS rolled back its intention to to set standards for plans' preferred provider networks, including requiring that they include any pharmacy that agrees to accept the terms.

    “Given the complexities of these issues and stakeholder input, we do not plan to finalize these proposals at this time,” Tavenner said in the letter. “We will engage in further stakeholder input before advancing some or all of the changes in these areas in future years.”

    Stuart Guterman, vice president for Medicare and Cost Control at the Commonwealth Fund, said the Obama administration's change of course “shows they are willing to listen to the feedback."

    But the decision to abandon plans to enforce the "any willing pharmacy" provision for pharmacy networks was a blow to community pharmacists, who say the CMS was swayed by large retailers like Wal-Mart and pharmacy benefit managers that own mail-order services, which have benefited from the restricted networks that are now employed in about 70% of Part D plans.

    “That's what drove a knife through my heart today,” said Jason Wallace, president of the Pharmacists United for Truth and Transparency, a coalition of independent pharmacists and pharmacy owners. “CMS recognized that there was a problem and basically someone way more powerful than you and I has convinced CMS otherwise."

    When the CMS released the proposed rule in January, it projected it would save $1.3 billion over five years. However, the Pharmaceutical Care Management Association, which represents pharmacy-benefit managers, said the document, if finalized, would actually increase costs to the federal government by $1.2 billion to $1.6 billion in 2015, according to a Milliman analysis it commissioned (PDF). Milliman based its findings on a survey of Part D plans and pharmacy-benefit managers that provide coverage to more than two- thirds of the 18.4 million Medicare Part D beneficiaries.

    Follow Virgil Dickson on Twitter: @MHvdickson

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    congress prescription drugs
    PBMs, Big Pharma face off in House hearing
    Biden COVID copy_i_i.jpg
    Biden administration asks employers to help more workers who lose Medicaid
    Most Popular
    1
    CMS tries luring providers to revamped Medicare ACOs
    2
    Oregon joins other states in setting ratios for nurse staffing
    3
    Blue Shield CA taps Amazon, Mark Cuban, CVS for new PBM model
    4
    A health innovation hub grows in Lake Nona Medical City
    5
    Hospital-at-home providers push for Medicaid coverage
    Sponsored Content
    Modern Healthcare Alert: Sign up for this breaking news email to be kept in the loop as urgent healthcare business news unfolds.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Help Center
    • Advertise with Us
    • Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Blogs
      • AI
      • Deals
      • Layoff Tracker
      • HIMSS 2023
    • Opinion
      • Breaking Bias
      • Commentaries
      • Letters
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Digital Health Transformation Summit
        • ESG: The Implementation Imperative Summit
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Hospital at Home
        • - Workplace of the Future
        • - AI and Digital Health
        • - Future of Staffing
        • - Hospital of the Future (Fall)
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Sponsored Video Series - One on One
      • Sponsored Video Series - Checking In with Dan Peres
    • Data & Insights
      • Data & Insights Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing